Janssen Hits GE Unit With Patent Suit Over Biosimilar
Janssen Biotech Inc. on Tuesday accused a General Electric unit in Utah federal court of infringing its patent for a cell culture media used to grow Inflectra, Celltrion Healthcare Co. and...To view the full article, register now.
Already a subscriber? Click here to view full article